1. The 2015 World Health Organization Classification of Lung Tumors
2. 张童童, 李峻岭. 存在驱动基因突变肺鳞癌患者的临床病理特征及预后分析[J]. 中国肺癌杂志, 2016, 19(10): 648-652.
3. Peripheral blood biomarkers correlate with outcomes in advanced non-small cell lung Cancer patients treated with anti-PD-1 antibodies
4. 唐高燕, 刘琰, 张青云, 等. NLR和PLR动态变化预测PD-1/PD-L1治疗晚期非小细胞肺癌患者疗效及预后的价值[J]. 现代肿瘤医学, 2023, 31(12): 2247-2254.
5. Khan, S., Jain, M., Mathur, V., et al. (2016) Chronic Inflammation and Cancer: Paradigm on Tumor Progression, Metastasis and Therapeutic Intervention. Gulf Journal of Oncology, 1, 86-93.